This result has implication in the use of ENO1 as a therapeutic treatment during Chlamydia infection; in addition, it has been shown that ENO1 deoxyribonucleic acid elicits humoral and cellular immune responses against pancreatic tumors, delays tumor progression [43]. This evidence concerns the gene ENO1 and chlamydia infectious disease.